Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Feb 9, 2026
Sale
Shares
1
Price
$784.66
Total Value
$784.66
Shares Held After
4,325
% of Holdings
0.0%
Feb 9, 2026
Sale
Shares
144
Price
$783.23
Total Value
$112.79K
Shares Held After
4,326
% of Holdings
3.2%
Feb 9, 2026
Sale
Shares
37
Price
$782.67
Total Value
$28.96K
Shares Held After
4,470
% of Holdings
0.8%
Feb 9, 2026
Sale
Shares
26
Price
$781.37
Total Value
$20.32K
Shares Held After
4,507
% of Holdings
0.6%
Feb 9, 2026
Sale
Shares
75
Price
$780.06
Total Value
$58.50K
Shares Held After
4,533
% of Holdings
1.6%
Feb 9, 2026
Sale
Shares
205
Price
$779.56
Total Value
$159.81K
Shares Held After
4,608
% of Holdings
4.3%
Feb 9, 2026
Sale
Shares
563
Price
$778.35
Total Value
$438.21K
Shares Held After
4,813
% of Holdings
10.5%
Feb 9, 2026
Sale
Shares
391
Price
$777.51
Total Value
$304.01K
Shares Held After
5,376
% of Holdings
6.8%
Feb 9, 2026
Sale
Shares
521
Price
$776.43
Total Value
$404.52K
Shares Held After
5,767
% of Holdings
8.3%
Feb 9, 2026
Sale
Shares
20
Price
$775.95
Total Value
$15.52K
Shares Held After
6,288
% of Holdings
0.3%
Feb 9, 2026
Purchase
Shares
115,000
Price
$16.00
Total Value
$1.84M
Shares Held After
251,427
% of Holdings
45.7%
Feb 9, 2026
Purchase
Shares
20,000
Price
$16.00
Total Value
$320.00K
Shares Held After
25,450
% of Holdings
78.6%
Feb 9, 2026
Purchase
Shares
312,500
Price
$16.00
Total Value
$5.00M
Shares Held After
2,187,513
% of Holdings
14.3%

Entera Bio Ltd. (ENTX)

Ellis Sean — Director
Feb 9, 2026
Purchase
Shares
18,000
Price
$1.24
Total Value
$22.32K
Shares Held After
178,098
% of Holdings
10.1%

Entera Bio Ltd. (ENTX)

Rubin Steven D — Director
Feb 9, 2026
Purchase
Shares
10,000
Price
$1.20
Total Value
$12.00K
Shares Held After
10,000
% of Holdings
100.0%
Feb 9, 2026
Sale
Shares
889
Price
$2.39
Total Value
$2.13K
Shares Held After
79,133
% of Holdings
1.1%

Zentalis Pharmaceuticals, Inc. (ZNTL)

Bruns Ingmar — Chief Medical Officer
Feb 9, 2026
Sale
Shares
335
Price
$2.39
Total Value
$801.62
Shares Held After
33,332
% of Holdings
1.0%
Feb 9, 2026
Sale
Shares
3,379
Price
$2.39
Total Value
$8.09K
Shares Held After
153,400
% of Holdings
2.2%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 9, 2026
Sale
Shares
7,875
Price
$474.65
Total Value
$3.74M
Shares Held After
0
% of Holdings
100.0%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 9, 2026
Sale
Shares
14,625
Price
$474.65
Total Value
$6.94M
Shares Held After
0
% of Holdings
100.0%

ACADIA PHARMACEUTICALS INC (ACAD)

Rhodes Jennifer J — EVP, CHIEF LEGAL OFFICER, SEC
Feb 9, 2026
Sale
Shares
6,950
Price
$23.38
Total Value
$162.49K
Shares Held After
7,609
% of Holdings
47.7%
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
Feb 9, 2026
Purchase
Shares
165,000
Price
$16.00
Total Value
$2.64M
Shares Held After
3,310,619
% of Holdings
5.0%
Feb 9, 2026
Sale
Shares
14,625
Price
$8.56
Total Value
$125.19K
Shares Held After
387,225
% of Holdings
3.6%
Feb 9, 2026
Sale
Shares
17,159
Price
$21.03
Total Value
$360.82K
Shares Held After
491,690
% of Holdings
3.4%

Syndax Pharmaceuticals, Inc. (SNDX)

Goldan Keith A. — Chief Financial Officer
Feb 9, 2026
Sale
Shares
3,410
Price
$21.03
Total Value
$71.71K
Shares Held After
140,429
% of Holdings
2.4%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Feb 9, 2026
Sale
Shares
14,261
Price
$16.66
Total Value
$237.62K
Shares Held After
42,749
% of Holdings
25.0%
Feb 6, 2026
Sale
Shares
7,866
Price
$2.43
Total Value
$19.11K
Shares Held After
80,022
% of Holdings
9.0%

Zentalis Pharmaceuticals, Inc. (ZNTL)

Bruns Ingmar — Chief Medical Officer
Feb 6, 2026
Sale
Shares
2,962
Price
$2.43
Total Value
$7.20K
Shares Held After
33,667
% of Holdings
8.1%
Feb 6, 2026
Sale
Shares
29,951
Price
$2.43
Total Value
$72.77K
Shares Held After
156,779
% of Holdings
16.0%

Cingulate Inc. (CING)

Brams Matthew — EVP and Chief Medical Officer
Feb 6, 2026
Purchase
Shares
1,946
Price
$5.04
Total Value
$9.81K
Shares Held After
4,656
% of Holdings
41.8%
Feb 6, 2026
Purchase
Shares
6,809
Price
$5.04
Total Value
$34.32K
Shares Held After
10,175
% of Holdings
66.9%

Cingulate Inc. (CING)

Callahan Jennifer L. — SVP and CFO
Feb 6, 2026
Purchase
Shares
4,864
Price
$5.04
Total Value
$24.51K
Shares Held After
5,059
% of Holdings
96.1%

Cingulate Inc. (CING)

Werth Peter J. — Director
Feb 6, 2026
Purchase
Shares
19,455
Price
$5.04
Total Value
$98.05K
Shares Held After
117,449
% of Holdings
16.6%

Enliven Therapeutics, Inc. (ELVN)

Lyssikatos Joseph P — CHIEF SCIENTIFIC OFFICER
Feb 6, 2026
Sale
Shares
5,000
Price
$29.04
Total Value
$145.22K
Shares Held After
740,188
% of Holdings
0.7%
Feb 6, 2026
Sale
Shares
29,430
Price
$85.79
Total Value
$2.52M
Shares Held After
254,497
% of Holdings
10.4%

Spero Therapeutics, Inc. (SPRO)

Keutzer Timothy — Chief Operating Officer
Feb 6, 2026
Sale
Shares
18,652
Price
$2.36
Total Value
$44.02K
Shares Held After
742,506
% of Holdings
2.5%

Spero Therapeutics, Inc. (SPRO)

Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Feb 6, 2026
Sale
Shares
50,816
Price
$2.36
Total Value
$119.93K
Shares Held After
1,012,091
% of Holdings
4.8%

Spero Therapeutics, Inc. (SPRO)

Rajavelu Esther — Chief Executive Officer, Chief Financial Officer and Chief Business Officer
Feb 6, 2026
Sale
Shares
37,101
Price
$2.36
Total Value
$87.56K
Shares Held After
1,062,907
% of Holdings
3.4%

CODEXIS, INC. (CDXS)

MOORE ALISON — Director
Feb 6, 2026
Sale
Shares
3,826
Price
$1.31
Total Value
$5.00K
Shares Held After
250,506
% of Holdings
1.5%

CODEXIS, INC. (CDXS)

Erbez Georgia — Chief Financial Officer and Chief Business Officer
Feb 6, 2026
Sale
Shares
3,826
Price
$1.31
Total Value
$5.00K
Shares Held After
66,810
% of Holdings
5.4%

CODEXIS, INC. (CDXS)

Lutz Stefan — Chief Scientific Officer
Feb 6, 2026
Sale
Shares
2,492
Price
$1.31
Total Value
$3.26K
Shares Held After
136,283
% of Holdings
1.8%
Feb 6, 2026
Purchase
Shares
50,000
Price
$0.95
Total Value
$47.28K
Shares Held After
1,888,551
% of Holdings
2.6%
Feb 6, 2026
Purchase
Shares
300
Price
$2.70
Total Value
$810.00
Shares Held After
65,682
% of Holdings
0.5%

Syndax Pharmaceuticals, Inc. (SNDX)

Goldan Keith A. — Chief Financial Officer
Feb 6, 2026
Sale
Shares
2,082
Price
$20.62
Total Value
$42.93K
Shares Held After
143,839
% of Holdings
1.4%
Feb 6, 2026
Sale
Shares
7,412
Price
$20.62
Total Value
$152.84K
Shares Held After
508,849
% of Holdings
1.4%
Feb 6, 2026
Sale
Shares
20,000
Price
$83.68
Total Value
$1.67M
Shares Held After
7,825
% of Holdings
71.9%

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Smith Hunter C — Chief Financial Officer
Feb 5, 2026
Sale
Shares
3,381
Price
$106.06
Total Value
$358.60K
Shares Held After
125,537
% of Holdings
2.6%

INSMED Inc (INSM)

Flammer Martina M.D. — Chief Medical Officer
Feb 5, 2026
Sale
Shares
869
Price
$152.44
Total Value
$132.47K
Shares Held After
83,243
% of Holdings
1.0%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Feb 5, 2026
Sale
Shares
15,000
Price
$61.93
Total Value
$928.95K
Shares Held After
50,440
% of Holdings
22.9%
Version: v26.3.33